RCS - Infex Therapeutics - First NCFB patient dosed in RESP-X Phase IIa study16/09/2024 08:15Announcement
RCS - ENDRA Life Sciences - ENDRA Announces New Clinical Study Partnership 04/12/2020 09:15Announcement
Last trade - 00:00Last trade - 00:00Last trade - 00:00